Varma Mutual Pension Insurance Co Purchases Shares of 35,515 Synopsys, Inc. $SNPS

Varma Mutual Pension Insurance Co purchased a new position in Synopsys, Inc. (NASDAQ:SNPS) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 35,515 shares of the semiconductor company’s stock, valued at approximately $15,842,000.

A number of other large investors have also modified their holdings of SNPS. Dream Peak Capital Ltd acquired a new position in shares of Synopsys during the second quarter valued at about $132,592,000. Westpac Banking Corp acquired a new stake in Synopsys in the 2nd quarter worth approximately $1,026,000. TRB Wealth Management LLC acquired a new stake in Synopsys in the 2nd quarter worth approximately $216,000. Sumitomo Life Insurance Co. purchased a new stake in Synopsys during the 2nd quarter worth approximately $2,095,000. Finally, Korea Investment CORP acquired a new position in Synopsys during the 2nd quarter valued at approximately $62,264,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Synopsys Stock Down 0.0%

SNPS stock opened at $397.87 on Friday. The company has a market capitalization of $76.18 billion, a P/E ratio of 92.10, a price-to-earnings-growth ratio of 2.34 and a beta of 1.23. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $615.79. The firm’s fifty day simple moving average is $419.73 and its 200-day simple moving average is $440.22. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.15 by $0.20. The firm had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm’s revenue was up 41.9% compared to the same quarter last year. During the same quarter last year, the company posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities research analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Insider Transactions at Synopsys

In related news, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 0.56% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on SNPS shares. Robert W. Baird set a $558.00 price target on shares of Synopsys in a report on Thursday, May 28th. Piper Sandler raised Synopsys from a “neutral” rating to an “overweight” rating and upped their target price for the company from $450.00 to $550.00 in a research report on Tuesday, June 23rd. Morgan Stanley reduced their target price on Synopsys from $525.00 to $500.00 and set an “equal weight” rating for the company in a research note on Wednesday. Rosenblatt Securities boosted their price target on Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a research note on Tuesday, May 26th. Finally, Zacks Research raised Synopsys from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 30th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $563.59.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.